Cargando…
Epigenetics and Beyond: Targeting Histone Methylation to Treat Type 2 Diabetes Mellitus
Diabetes mellitus is a global public health challenge with high morbidity. Type 2 diabetes mellitus (T2DM) accounts for 90% of the global prevalence of diabetes. T2DM is featured by a combination of defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to r...
Autores principales: | Yang, Yang, Luan, Ying, Feng, Qi, Chen, Xing, Qin, Bo, Ren, Kai-Di, Luan, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788853/ https://www.ncbi.nlm.nih.gov/pubmed/35087408 http://dx.doi.org/10.3389/fphar.2021.807413 |
Ejemplares similares
-
New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis
por: Luan, Yi, et al.
Publicado: (2022) -
Histone Methylation Related Therapeutic Challenge in Cardiovascular Diseases
por: Yang, Yang, et al.
Publicado: (2021) -
Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases
por: Yang, Yang, et al.
Publicado: (2023) -
Rhein for treating diabetes mellitus: A pharmacological and mechanistic overview
por: Deng, Tingting, et al.
Publicado: (2023) -
Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
por: Feng, Jianwei, et al.
Publicado: (2022)